DOK7 Antikörper (AA 63-320)
-
- Target Alle DOK7 Antikörper anzeigen
- DOK7 (Docking Protein 7 (DOK7))
-
Bindungsspezifität
- AA 63-320
-
Reaktivität
- Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DOK7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (fixed cells) (IF/ICC), Immunoprecipitation (IP)
- Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Immunogen
- DOK7 (Trp63-Gly320)
- Top Product
- Discover our top product DOK7 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 500 μg/mL
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
-
- Target
- DOK7 (Docking Protein 7 (DOK7))
- Andere Bezeichnung
- Docking Protein 7 (DOK7 Produkte)
- Synonyme
- si:dkey-180b4.3 antikoerper, si:ch211-164d19.2 antikoerper, C4orf25 antikoerper, CMS1B antikoerper, A930013K19Rik antikoerper, AW049091 antikoerper, Dok-7 antikoerper, EF-12 antikoerper, Oit5 antikoerper, RGD1566416 antikoerper, dok-7 antikoerper, docking protein 7 antikoerper, DOK7 antikoerper, dok7 antikoerper, Dok7 antikoerper
- Pathways
- Skeletal Muscle Fiber Development
-